BeStock  
Stocks › Biotechnology › IDYA

IDEAYA Biosciences IDYA

US equityMarket cap rank #2556Biotechnology
$25.56 −$0.61 (-2.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.56 0.00%
Open$25.83
Prev close$26.17
Day range$25.46 – $26.87
Volume1.11M
Market cap$2.47B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

IDYA at a glance

Shares of IDEAYA Biosciences are down 2.33% at $25.56. The company is worth $2.47B, number 2556 out of 3753 on our list.

It is close to the bottom of its 52-week range ($25.46 to $42.68), 40.1% under the high. Holders are behind 24.8% over twelve months, and down 36.2% across the last three months.

On the chart it has slipped under both the 50-day ($34.34) and 200-day ($33.70) moving averages; RSI is 25, which some call oversold, and the last 30 sessions moved at roughly 53% annualized volatility.

For the quarter ended Sep 2026 it reported $10.24M in revenue, down 95.1% from a year earlier, and a net loss of $125.75M.

11 analysts follow the stock and the average call is "buy". The mean target, $52.90, sits 107.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$25.42 / $28.58
Average price today$25.78
Volume1.11MAvg (90d) 879.4K
Turnover$28.72M
Turnover rate1.23%of shares outstanding
Volume ratio0.89vs. recent average pace
Day amplitude5.40%
Market cap$2.47B
Float market cap$2.32B
Shares outstanding90.84M
EPS (TTM)-$1.28
P/B2.26
Book value / share$11.29
Net profit (TTM)-$123.77M
Net assets$1.09B
30-day volatility52.8%annualized
Avg daily range (ATR)6.86%of price, 14 days
Max drawdown (1y)-39.8%-39.8% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

11 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 40.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability7.1
Momentum21.3
Financial health98.5
Analyst view91.3

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$52.90+107.0% vs. current price
Consensus ratingBuy11 analysts covering
Morningstar fair value$35.87Price is below fair value

Wall Street’s average 12-month target is $52.90, 107.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $35.87, so shares trade 28.7% below that estimate. On earnings multiple, it sits in the 83rd percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-2.3%
1 week
-19.7%
1 month
-29.2%
3 months
-36.2%
6 months
-12.2%
Year to date
-26.1%
1 year
-24.8%
Day range
$25.46$26.87
52-week range
$25.46$42.68

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 4 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-17.3%Bearish
Price vs 50-day average-25.6%Bearish
Price vs 200-day average-24.2%Bearish
50-day vs 200-day50d above 200dBullish
RSI (14)25.1Neutral
MACD (12,26,9)-2.12Bearish
Bollinger band position-4%Neutral

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How IDYA ranks on BeStock

Market value#2545 of 3734
Closeness to 52-week high#2675 of 3724
Dollar volume today#1783 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

IDYA is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on IDYA.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on IDYA

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

IDYA stock: common questions

How is IDEAYA Biosciences stock doing today?

$25.56 is the latest print for IDYA, a move of -2.33% against yesterday's close of $26.17. Today's low and high so far: $25.46 and $26.87.

How large is IDEAYA Biosciences by market value?

Equity value comes to $2.47B at the current price. By that measure it is number 2556 of the 3753 names in our coverage.

Is IDYA near its 52-week high or low?

The year's floor is $25.46 and the ceiling $42.68. Shares are 40.1% away from that ceiling.

Does IDEAYA Biosciences pay a dividend?

Our data shows no dividend paid by IDEAYA Biosciences over the trailing twelve months.

Is IDYA rated a buy by Wall Street?

Of 11 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $52.90, with the most cautious at $39.00 and the most optimistic at $66.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on IDYA.

Sign in to join the discussion.

Scroll to Top